CI vs DAWN · P/E 2.4, rev $274.90B vs rev $131.2M
Cigna Corp (CI) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the CI and DAWN stock pages for the full models.
Not investment advice.